Japan Over the Counter (OTC) Drugs & Dietary Supplements Market and Forecast 2020-2026

  • TBI493617
  • October 07, 2020
  • Japan
  • 132 pages
  • ROIF Expert
                                          

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.

Market Analysis and Insights: Japan Over the Counter (OTC) Drugs & Dietary Supplements Market

This report focuses on Japan Over the Counter (OTC) Drugs & Dietary Supplements market. The Japan Over the Counter (OTC) Drugs & Dietary Supplements market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Japan Over the Counter (OTC) Drugs & Dietary Supplements Scope and Market Size

Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into

  • Analgesic & pain relievers
  • Dermatological products
  • Cough, cold, and flu products
  • Vitamin supplements
  • Mineral Supplements
  • Ophthalmic Products

Segment by Application

the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into

  • Pharmacies
  • Grocery Stores
  • Vitamin
  • Health Food Stores
  • Online Pharmacies

Regional and Country-level Analysis

The Over the Counter (OTC) Drugs & Dietary Supplements market is analysed and market size information is provided by regions (countries). The key regions covered in the Over the Counter (OTC) Drugs & Dietary Supplements market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Over the Counter (OTC) Drugs & Dietary Supplements Market Share Analysis

Over the Counter (OTC) Drugs & Dietary Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over the Counter (OTC) Drugs & Dietary Supplements business, the date to enter into the Over the Counter (OTC) Drugs & Dietary Supplements market, Over the Counter (OTC) Drugs & Dietary Supplements product introduction, recent developments, etc.

The major vendors covered:

  • Pfizer Inc.
  • Novartis International AG
  • Roche Holding AG
  • Merck & Co., Inc.
  • Sanofi S.A
  • Johnson & Johnson
  • Gilead Sciences
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AstraZeneca plc.
  • Alacer Corp.
  • Alcon Inc.
  • Alfresa Pharma Corporation
  • Alkalon A/S
  • Alliance Healthcare
  • Allergan, Plc.
  • Reckitt Benckiser Plc.
  • Bausch & Lomb
  • AbbVie Inc.
  • The Colgate-Palmolive Company

Table of Contents

Chapter 1. Preface
	
		1.1. Report Description
		
			1.1.1. Objective
			1.1.2. Target Audience
			1.1.3. Unique Selling Proposition (USP) & Offerings
		
		
		1.2. Research Scope
		1.3. Research Methodology
		
			1.3.1. Market Research Process
			1.3.2. Market Research Methodology
			1.3.3. Level 1: Primary Research
			1.3.4. Level 2: Secondary Research
			1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
			
Chapter 2. Executive Summary
	
		2.1. Global Japan Over the Counter (OTC) Drugs & Dietary Supplements 2019-2029 (USD Billion)
		2.2. Global Japan Over the Counter (OTC) Drugs & Dietary Supplements: Market Snapshot
	 
Chapter 3. Global Japan Over the Counter (OTC) Drugs & Dietary Supplements - Industry Analysis
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form